18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging? - 09/08/19
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Pancreatic ductal adenocarcinoma represents 90% of all pancreatic tumors. The only hope for prolonged survival in patients with this condition still remains surgery with complete R0 resection. Initial imaging has a pivotal role to identify patients who are eligible to curative surgery and those who may benefit of neoadjuvant chemotherapy. This review provides an analysis of the recent literature on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in pancreatic adenocarcinoma. Performances of FDG PET in the detection of lymph node involvement and metastatic spread at initial staging and those in the assessment of response to treatment are described.
Le texte complet de cet article est disponible en PDF.Keywords : Pancreatic adenocarcinoma, 18F-Fluorodeoxyglucose positron emission tomography (FDG PET/CT), Imaging
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?